223 related articles for article (PubMed ID: 23970578)
1. Endocrine and metabolic abnormalities among HIV-infected patients: a current review.
Kibirige D; Ssekitoleko R
Int J STD AIDS; 2013 Aug; 24(8):603-11. PubMed ID: 23970578
[TBL] [Abstract][Full Text] [Related]
2. Endocrine and metabolic disorders associated with human immune deficiency virus infection.
Unachukwu CN; Uchenna DI; Young EE
West Afr J Med; 2009 Jan; 28(1):3-9. PubMed ID: 19662737
[TBL] [Abstract][Full Text] [Related]
3. Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease.
Cooper OB; Brown TT; Dobs AS
Clin Infect Dis; 2003; 37 Suppl 2():S132-6. PubMed ID: 12942387
[TBL] [Abstract][Full Text] [Related]
4. Metabolic complications in HIV infection. In search of underlying mechanisms.
Johnson DL
Adv Nurse Pract; 2002 Jul; 10(7):45-50, 76. PubMed ID: 12420551
[No Abstract] [Full Text] [Related]
5. Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival.
Leonard EG; McComsey GA
Infect Dis Clin North Am; 2005 Sep; 19(3):713-29. PubMed ID: 16102657
[TBL] [Abstract][Full Text] [Related]
6. The metabolic toxicities of antiretroviral therapy.
Herman JS; Easterbrook PJ
Int J STD AIDS; 2001 Sep; 12(9):555-62; quiz 563-4. PubMed ID: 11516363
[TBL] [Abstract][Full Text] [Related]
7. Metabolic and morphologic complications of HIV infection.
Eid AJ; Orenstein R
J Med Liban; 2006; 54(2):97-105. PubMed ID: 17087001
[TBL] [Abstract][Full Text] [Related]
8. HIV-associated lipodystrophy, metabolic complications, and antiretroviral toxicities.
Moyle G; Carr A
HIV Clin Trials; 2002; 3(1):89-98. PubMed ID: 11894812
[No Abstract] [Full Text] [Related]
9. Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease.
Anuurad E; Semrad A; Berglund L
Metab Syndr Relat Disord; 2009 Oct; 7(5):401-10. PubMed ID: 19355810
[TBL] [Abstract][Full Text] [Related]
10. [Metabolic abnormalities, lipodystrophy and cardiovascular risk in HIV-infected patients].
Leclercq P; Blanc M
Rev Prat; 2006 May; 56(9):987-94. PubMed ID: 16775979
[TBL] [Abstract][Full Text] [Related]
11. [Lipodystrophy and lipid metabolism alterations in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
Calza L; Manfredi R; Chiodo F
Recenti Prog Med; 2004 May; 95(5):265-75. PubMed ID: 15202680
[TBL] [Abstract][Full Text] [Related]
12. [Lipodystrophy syndrome in HIV-infected patients. Clinical and diagnostic features].
Streinu-Cercel A; Ion DA; Chivu LI; Chivu RD
Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):521-5. PubMed ID: 17571539
[TBL] [Abstract][Full Text] [Related]
13. Metabolic disorders and cardiovascular risk in HIV-infected patients treated with antiretroviral agents.
Fantoni M; Del Borgo C; Autore C; Barbaro G
Ital Heart J; 2002 May; 3(5):294-9. PubMed ID: 12066561
[TBL] [Abstract][Full Text] [Related]
14. [Endocrine-metabolic changes in patients infected with the human immunodeficiency virus].
Alvarez Hernández J
Rev Clin Esp; 1994 May; 194(5):352-60. PubMed ID: 8059033
[No Abstract] [Full Text] [Related]
15. The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment.
Crook M
Ann Clin Biochem; 2007 May; 44(Pt 3):219-31. PubMed ID: 17456292
[TBL] [Abstract][Full Text] [Related]
16. Endocrine complications associated with human immunodeficiency virus infection.
Etzel JV; Brocavich JM; Torre M
Clin Pharm; 1992 Aug; 11(8):705-13. PubMed ID: 1511543
[TBL] [Abstract][Full Text] [Related]
17. Toxicities of antiretroviral therapy in children.
Nwaobasi E; Oleske JM
AIDS Read; 2006 Oct; 16(10):537-40, 544-6,549-50, 552-4. PubMed ID: 17096472
[TBL] [Abstract][Full Text] [Related]
18. Interventions for metabolic and endocrine complications of human immunodeficiency virus/acquired immune deficiency syndrome and illicit drug use.
Khalsa JH; Genser S; Coates P; Francis H
Clin Infect Dis; 2003; 37 Suppl 2():S37-42. PubMed ID: 12942372
[TBL] [Abstract][Full Text] [Related]
19. Metabolic complications of HIV-1 antiretroviral therapy: the lipodystrophy syndrome.
Borderi M; Verucchi G; Tadolini M; Spinosa S; Fortunato L; Talò S; Chiodo F
New Microbiol; 2001 Jul; 24(3):303-15. PubMed ID: 11497090
[TBL] [Abstract][Full Text] [Related]
20. [Coronary heart disease associated with the use of highly active antiretroviral therapy (HAART). A case report and review].
Neumann T; Kondratieva J; Eggebrecht H; Wieneke H; Esser S; Bartel T; Erbel R
Herz; 2005 Sep; 30(6):504-9. PubMed ID: 16170681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
